Patients with androgenetic alopecia need a structured hair restoration protocol, exosomes, PRP, or medical management, with GHK-Cu as a complementary add-on, not the primary treatment
Older people, vegans and vegetarians, and people with gastrointestinal issues are all at risk of B-12 deficiency either because theyre not going to be consuming enough sources of B-12, or because theyre not able to absorb it properly
Why the FDA Position Is What It Is The regulatory reasoning behind peptide category adjustments is typically a combination of: Absence of sufficient human clinical trial data to support inclusion Manufacturing and quality control standardization questions The availability of alternative therapies Pharmacovigilance considerations arising from compounding pharmacy use patterns A physician hearing not approved about a compound that has been clinically useful may understandably feel that the regulatory posture is out of step with clinical experience
The Bottom Line: Compelling Mechanisms Demand Rigorous Human Investigation BPC-157 presents a fascinating scientific paradox: extensive preclinical evidence spanning three decades demonstrates pleiotropic effects across multiple neurotransmitter systems, with antidepressant efficacy exceeding standard drugs in animal models, anxiolytic effects without dependence liability, neuroprotection in stroke and neurodegeneration models, and reversal of schizophrenia-like cognitive deficits
We use precise dosages and monitor your health to ensure safe and effective treatment
